ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 2203 • 2014 ACR/ARHP Annual Meeting

    Adalimumab Therapy Improves Insulin Sensitivity in Non-Diabetic Psoriatic Patients: A 6-Month Prospective Study

    Trinitario Pina Murcia1, Raquel López-Mejías1, Fernanda Genre1, Begoña Ubilla1, Susana Armesto2, Marcos A. González-López2, María del Carmen Gonzalez-Vela3, Javier Llorca4, Ricardo Blanco5 and MA González-Gay1, 1Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, 2Dermatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain, 3Dept. of Pathology, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria, Santander, Spain, 4Department of Epidemiology and Computational Biology, School of Medicine, University of Cantabria, and CIBER Epidemiología y Salud Pública (CIBERESP), IDIVAL, Santander, Spain, 5Hospital Marques de Valdecilla, Santander, Spain

    Background/Purpose: psoriasis is a systemic inflammatory condition that shares similarities with other inflammatory immune disorders. In this context, patients with psoriasis are at an increased…
  • Abstract Number: 2204 • 2014 ACR/ARHP Annual Meeting

    New Onset Vitiligo Under Biological Agents: A Case Series

    Laure Mery-Bossard1, Emmanuelle Mahé2, Guillaume Charby3, François Maccari4, Nathalie Quilès5, Ziad Reguiai6, Abdallah Khemis7, Anne Grasland8, Morgane Guerin9, Denis Jullien10, Kelly Bagny11, Jean Sibilia12, Eric Toussirot13,14 and Resopso Le CRI15, 1Dermatology, Centre hospitalier, Mantes la Jolie, France, 2Dermatology, Centre hospitalier, Argenteuil, France, 3Dermatology, University hospital, Amiens, France, 4Dermatology, Centre hospitalier, Saint Mandé, France, 5Dermatology, University hospital, Marseille, France, 6Dermatology, Uniersity hospital, Reims, France, 7Dermatology, University hospital, Nice, France, 8Internal medicine, University hospital, Colombe, France, 9Dermatology, University hospital, Lyon, France, 10Pavillon r dermatologie, Hopital Edouard Herriot, Lyon, France, 11Rheumatology, University hospital, La Réunion, France, 12Division of Rheumatology, University Hospital of Strasbourg, Strasbourg, France, 13Clinical Investigation Centre Biotheraoy CIC 1431, Rheumatology Department, Univesity Hospital, besancon, France, 14Rheumatology, University hospital, Besançon, France, 15University Hospital, Paris, France

    Background/Purpose: biological agents are now widely used in clinical practice for the treatment of chronic cutaneous, rheumatic and gastro-intestinal inflammatory diseases. Various cutaneous lesions have…
  • Abstract Number: 2205 • 2014 ACR/ARHP Annual Meeting

    Management of Asymptomatic Coccidioidomycosis in Patients with Rheumatic Disease

    Dominick Sudano1, Varun Bhalla2, Neil M. Ampel3,4 and Jeffrey R. Lisse5, 1Rheumatology, University of Arizona, Tucson, AZ, 2University of Arizona, Tucson, AZ, 3Infectious Disease, University of Arizona, Tucson, AZ, 4Infectious Disease, Southern Arizona Veteran's Affairs Medical Center, Tucson, AZ, 5Department of Rheumatology, University of Arizona, Tucson, AZ

    Background/Purpose: In the Southwestern United States, coccidioidomycosis (valley fever) is an endemic fungal infection which typically causes a self-limited pulmonary illness. Immunosuppressed patients, including those…
  • Abstract Number: 2206 • 2014 ACR/ARHP Annual Meeting

    The Incidence of Zoster in Patients with Cutaneous Lupus Erythematosus and Dermatomyositis Is Increased Compared to the Average U.S. Population

    Elizabeth S. Robinson1,2, Joyce Okawa1,2, Rui Feng3, Aimee S. Payne2 and Victoria P. Werth1,4, 1Department of Dermatology, Veteran Affairs Medical Center, Philadelphia, PA, 2Department of Dermatology, University of Pennsylvania, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 4University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Herpes zoster is a common condition that causes significant pain and, often, post-herpetic neuralgia. In the United States the incidence of zoster per 1,000…
  • Abstract Number: 2207 • 2014 ACR/ARHP Annual Meeting

    Decreased Bone Mineral Density in Patients with Ehler-Danlos Syndrome

    Narender Annapureddy1, Joel A. Block2 and Sonali Khandelwal1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Section of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Ehler-Danlos Syndrome (EDS) constitutes a heterogeneous group of inherited connective tissue disorders characterized by abnormalities of collagen I, III, V, or fibronectin, and primarily…
  • Abstract Number: 2208 • 2014 ACR/ARHP Annual Meeting

    Ovarian Reserve Alterations in Premenopausal Women with Rheumatoid Arthritis, Behcet’s Disease and Spondyloarthritis – Impact on Anti-Muellerian Hormone Levels

    Joerg C. Henes1, Julia Froeschlin2, Andre Taran3, Theodoros Xenitidis4 and Melanie Henes5, 1Department of Internal Medicine II, Rheumatology Division, University Hospital Tuebingen, Tuebingen, Germany, 2University Tuebingen, Tuebingen, Germany, 3University Hospital for Women Tuebingen, Tuebingen, Germany, 4Internal Medincine II, devision for Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, 5University Hospital for Women, Tuebingen, Germany

    Background/Purpose: Recent publications showed a negative influence of systemic lupus erythematosus and antiphospholipid antibody syndrome on female ovarian reserve (OR). Other authors did not find…
  • Abstract Number: 2209 • 2014 ACR/ARHP Annual Meeting

    Novel Biomarkers of Extracellular Matrix Remodeling in Inflammatory Bowel Disease: Different Patterns of Gut Injury in UC and CD

    Joachim Høg Mortensen1, Line Elberg Godskesen2, Michael Dam Jensen2, Lone Gabriels Klinge2, Jens Kjeldsen2, Aleksander Krag2, Morten Karsdal3 and Anne C. Bay-Jensen4, 1Cartilage Biomarkers and Research, Nordic Bioscience, Købehavn, Denmark, 2Odense University Hospital, Odense, Denmark, 3Research & Development, Nordic Bioscience, Biomarkers and Research, Herlev, Denmark, 4Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark

     Background/Purpose: About 10 % of patients with IBD have symptoms that match both Crohn's disease (CD) and ulcerative colitis (UC), termed inflammatory bowel disease unclassified…
  • Abstract Number: 2210 • 2014 ACR/ARHP Annual Meeting

    Redefining Dermatomyositis: Description of New Diagnostic Criteria That Differentiate Pure Dermatomyositis from Overlap Myositis with Dermatomyositis Features

    Marie-Pier Payette1, Yves Troyanov1, Ira N. Targoff2, Jean-Pierre Raynauld1, Suzanne Chartier3, Jean-Richard Goulet1, Josiane Bourré-Tessier1, Eric Rich1, Tamara Grodzicky1, Marvin J. Fritzler4, France Joyal5, Martial Koenig5 and Jean-Luc Senécal1, 1Department of Medicine, Division of Rheumatology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 2Veterans Affairs Medical Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Division of Dermatology, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 4Mitogen Advanced Diagnostics Laboratory, Faculty of Medicine, University of Calgary, Calgary, AB, Canada, 5Department of Medicine, Division of Internal Medicine, Centre Hospitalier de l’Université de Montréal, Montreal, QC, Canada

    Background/Purpose: Dermatomyositis (DM) is a major form of autoimmune myositis (AIM). The characteristic DM rash (Gottron's papules, heliotrope rash) and perifascicular atrophy (PFA) at muscle…
  • Abstract Number: 2188 • 2014 ACR/ARHP Annual Meeting

    Incidence and Mortality of Relapsing Polychondritis in the United Kingdom: A Population-Based Cohort Study

    Nisha Hazra1, Alex Dregan1, Judith Charlton1, Martin C Gulliford1 and David P. D'Cruz2, 1Division of Primary Care and Public Health Research, King's College London, London, United Kingdom, 2Louise Coote Lupus Unit, Guy's and St Thomas' Hospital, London, United Kingdom

    Background/Purpose: To estimate the incidence, prevalence and mortality of Relapsing Polychondritis (RP), and to describe the clinical features of RP, in a large population.  Methods:…
  • Abstract Number: 2189 • 2014 ACR/ARHP Annual Meeting

    Multicentric Reticulohistiocytosis- Case Series from a Tertiary Care Center

    Namrata Singh1, Karolyn A Wanat2, Mary Stone2, Zuhair K. Ballas3 and Jacob W. Ijdo4, 1Medicine, University of Iowa, Iowa City, IA, 2Dermatology, University of Iowa, Iowa City, IA, 3Internal Medicine, Iowa City VA and the University of Iowa, Iowa City, IA, 4Internal Medicine, University of Iowa, Iowa City, IA

    Background/Purpose Multicentric Reticulohistiocytosis (MRH) is a rare systemic inflammatory disease with skin nodules and arthritis. On skin or joint biopsy the hallmark is the presence…
  • Abstract Number: 2190 • 2014 ACR/ARHP Annual Meeting

    Features of Interstitial Lung Disease Associated with Connective Tissue Disease in a Spanish Southwest Cohort

    Adela Gallego Flores1, Carmen Carrasco Cubero2, Raul Veroz Gonzalez1, Luz Maria Mellado Narciso1, Tamara Libertad Rodriguez Araya1, Juan Jose Aznar Sánchez1 and Eugenio Chamizo Carmona1, 1Rheumatology, Hospital de Mérida, Mérida, Spain, 2Rheumatology, Hospital de Merida, Mérida, Spain

    Background/Purpose Diffuse interstitial lung disease (ILD) can be associated with connective tissue diseases (CTD), and can increase morbidity and mortality significantly. The predominant patterns of…
  • Abstract Number: 2171 • 2014 ACR/ARHP Annual Meeting

    Polymorphisms in the FCN1 Gene Coding for M-Ficolin Are Associated with Disease Activity, Radiographic Damage and Are the Strongest Predictors of DAS28 Remission in 180 DMARD naïve Early Rheumatoid Arthritis Patients

    Christian G. Ammitzbøll1, Rudi Steffensen2, Steffen Thiel3, Jens Christian Jensenius3, Kim Horslev-Petersen4, Torkell Ellingsen5,6, Merete Lund Hetland7, Peter Junker8, Mikkel Ostergaard9 and Kristian Stengaard-Pedersen10, 1Arhus University Hospital, Aarhus, Denmark, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Biomedicine, Aarhus University, Aarhus, Denmark, 4Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Graasten, Denmark, 5Reumatology, Odense University Hospital, Odense, Denmark, 6Diagnostic Center, Regional Hospital Silkeborg, Silkeborg, Denmark, 7DANBIO, Department of Rheumatology, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 8Department of Rheumatology, Odense University Hospital, Odense, Denmark, 9Dept of Rheumatology RM, Copenhagen University Hospital, Glostrup, Denmark, 10Rheumatology, Arhus University Hospital, Aarhus, Denmark

    Background/Purpose: M-ficolin is a pattern recognition molecule that collaborates with associated serine proteases as an activator of the complement system. High M-ficolin levels are strongly…
  • Abstract Number: 2172 • 2014 ACR/ARHP Annual Meeting

    PTPN22 Promotes TLR-Induced Amelioration of Arthritis

    David Ewart1, Erik J. Peterson1 and Yaya Wang2, 1University of Minnesota, Minneapolis, MN, 2Center for Immunology, University of Minnesota, Minneapolis, MN

    Background/Purpose: Rheumatoid arthritis (RA) synovial fluid exhibits high levels of type 1 interferons (IFN). Type 1 IFN may exert potent anti-inflammatory effects, since a TLR3…
  • Abstract Number: 2173 • 2014 ACR/ARHP Annual Meeting

    Role of Natural Killer Cells and Gamma Delta T Cells in Enthesitis Related Arthritis Category of Juvenile Idiopathic Arthritis

    Priyanka Gaur1, Ramnath Misra2 and Amita Aggarwal2, 1Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India

    Background/Purpose:  Enthesitis Related Arthritis (ERA) is the most common form of Juvenile Idiopathic Arthritis (JIA) in India. ERA is associated with increased frequency of Th17…
  • Abstract Number: 2174 • 2014 ACR/ARHP Annual Meeting

    MicroRNA-146a in Salivary Gland Epithelial Cells Inhibits Co-Stimulatory Molecule CD80 Expression and Increases Autoreactive T Cell Activation in Sjögren’s Syndrome

    Adrienne Gauna1, Jun-O Jin2,3, Qing Yu2, Carol Stewart1 and Seunghee Cha1, 1Oral and Maxillofacial Diagnostic Sciences, University of Florida, Gainesville, FL, 2Department of Immunology and Infectious Diseases, The Forsyth Institute, Cambridge, MA, 3Shanghai Public Health Clinical Center, Fudan University Shanghai Medical College, Shanghai, China

    Background/Purpose: Sjögren’s syndrome (SS) causes severe dry mouth and eyes. The presence of immune cell infiltration in the salivary (SG) and lacrimal glands suggests a…
  • « Previous Page
  • 1
  • …
  • 1904
  • 1905
  • 1906
  • 1907
  • 1908
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology